Coagulation and Aging: Implications for the Anesthesiologist
Open Access
- 19 November 2021
- journal article
- research article
- Published by Springer Nature in Current Anesthesiology Reports
- Vol. 11 (4) , 387-395
Abstract
Purpose of Review: This narrative review focuses on aging-related modifications in coagulation resulting in increased thromboembolic and hemorrhagic risk of the elderly. We further discuss the current evidence and emerging data relating the perioperative treatment of elderly patients with antithrombotic therapy. Recent Findings: Relevant changes in all elements of the Virchow’s triad can be found with aging. Increased blood stasis due to immobility, progressive endothelial dysfunction with altered microcirculation, elevated concentrations of several coagulation factors, and increased platelet reactivity all lead to a procoagulant state. Elderly people are, therefore, commonly treated with oral anticoagulation and antiplatelet drugs. This antithrombotic therapy might be essentially causative for their increased bleeding risk. Summary: Elderly patients are at increased risk for thromboembolism due to changes in the hemostatic system in combination with frailty and multimorbidity. Both the thromboembolic due to aging and bleeding risk due to antithrombotic therapy need special attention in the elderly surgical patients.Keywords
Funding Information
- University of Basel
This publication has 76 references indexed in Scilit:
- Perioperative Management of Antithrombotic TherapyChest, 2012
- Principles and Practice of Thromboelastography in Clinical Coagulation Management and Transfusion PracticeTransfusion Medicine Reviews, 2012
- Venous thrombosis in the elderly: incidence, risk factors and risk groupsJournal of Thrombosis and Haemostasis, 2010
- Kidney Function Influences Warfarin Responsiveness and Hemorrhagic ComplicationsJournal of the American Society of Nephrology, 2009
- Hemostasis and ageingImmunity & Ageing, 2008
- The effect of chronic renal failure on drug metabolism and transportExpert Opinion on Drug Metabolism & Toxicology, 2008
- Elderly Medical Patients Treated with Prophylactic Dosages of EnoxaparinDrugs & Aging, 2007
- Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia∗∗The opinions and assertions expressed herein are those of the authors and are not to be construed as reflecting the views of the USUHS or the US Department of Defense.The American Journal of Cardiology, 2002
- Aging and ThrombosisSeminars in Thrombosis and Hemostasis, 2002
- Blood coagulation factors in the elderlyArchives of Gerontology and Geriatrics, 1989